probucol has been researched along with Hyperkalemia in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The 24-h proteinuria levels were significantly reduced in the probucol + telmisartan compared with telmisartan group." | 5.22 | Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study. ( Cai, G; Chen, X; Guan, X; Li, J; Li, W; Liu, M; Liu, W; Liu, Y; Lun, L; Wang, Y; Wu, H; Yao, H; Yin, S; Zhang, J; Zheng, Y; Zhou, C; Zhu, H; Zhuang, X, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, H | 1 |
| Chen, X | 1 |
| Cai, G | 1 |
| Zheng, Y | 1 |
| Liu, M | 1 |
| Liu, W | 1 |
| Yao, H | 1 |
| Wang, Y | 1 |
| Li, W | 1 |
| Wu, H | 1 |
| Lun, L | 1 |
| Zhang, J | 1 |
| Guan, X | 1 |
| Yin, S | 1 |
| Zhuang, X | 1 |
| Li, J | 1 |
| Liu, Y | 1 |
| Zhou, C | 1 |
1 trial available for probucol and Hyperkalemia
| Article | Year |
|---|---|
Telmisartan combined with probucol effectively reduces urinary protein in patients with type 2 diabetes: A randomized double-blind placebo-controlled multicenter clinical study.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Benzimidazoles; Benzoates; Blood Glucose; Chol | 2016 |